Cao, Jun
Teng, Yuee
Li, Huiping
Zhang, Lili
Ouyang, Quchang
Xie, Weimin
Pan, Yueyin
Song, Zhenchuan
Ling, Xiaoling
Wu, Xiaohong
Xu, Jingwei
Li, Li
Ren, Liping
Wang, Hong
Zhou, Dongxian
Luo, Jing
Hu, Xichun
Funding for this research was provided by:
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Article History
Received: 16 May 2023
Accepted: 23 July 2023
First Online: 9 August 2023
Declarations
:
: The study was conducted in accordance with the Declarations of Helsinki and Good Clinical Practice and was approved by the ethics committee of each participating center (approval number: 1903198–13, (2019) 2019–270, 2020YJZ11, 2019–029, 2020SR (No. 1), CS2019 (57), 2019KYER (No. 126), 2019155, (2019) ER (No. 22), (2020) RCR (No. 1), (S) ER (No. 2019051), LDYYLL2019-213, BF2019-145–01, SYL-201938–01, ER (R) 2019–235-01, R (2019) ER (No. 3)). All patients provided written informed consent.
: Not applicable.
: The authors declare that they have no competing interests.